Barclays PLC Pfizer Inc Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$27.7 - $31.39 $17.4 Million - $19.7 Million	628,300 Added 359.03%	803,300 $23.2 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $2.53 Million - $2.96 Million	100,000 Added 133.33%	175,000 $4.9 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $3.88 Million - $4.46 Million	-150,000 Reduced 66.67%	75,000 $2.08 Million
Q4 2023 Feb 15, 2024	BUY	$26.13 - $33.94 $5.88 Million - $7.64 Million	225,000 New	225,000 $6.48 Million
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $21.3 Million - $24.6 Million	-588,600 Reduced 70.42%	247,200 $9.07 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $1.93 Million - $2.51 Million	49,000 Added 6.23%	835,800 $34.1 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $20.1 Million - $26.2 Million	481,600 Added 157.8%	786,800 $40.3 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $7.4 Million - $9.04 Million	-169,200 Reduced 35.67%	305,200 $13.4 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $32.8 Million - $38.9 Million	-704,300 Reduced 59.75%	474,400 $24.9 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $21.3 Million - $31.6 Million	515,500 Added 77.73%	1,178,700 $69.6 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $14.8 Million - $19 Million	-376,000 Reduced 36.18%	663,200 $28.5 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $20.9 Million - $23.7 Million	582,800 Added 127.7%	1,039,200 $40.7 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $16.1 Million - $18.2 Million	-481,300 Reduced 51.33%	456,400 $16.5 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $471,927 - $600,096	-14,100 Reduced 1.48%	937,700 $34.5 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $1.67 Million - $1.96 Million	52,700 Added 5.86%	951,800 $34.9 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $4.05 Million - $4.91 Million	-134,400 Reduced 13.0%	899,100 $29.4 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $4.21 Million - $6.02 Million	-155,800 Reduced 13.1%	1,033,500 $33.7 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $10.8 Million - $12.3 Million	329,400 Added 38.31%	1,189,300 $46.6 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $15.2 Million - $19.7 Million	467,900 Added 119.36%	859,900 $30.9 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $2.3 Million - $2.58 Million	-62,100 Reduced 13.68%	392,000 $17 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $19.5 Million - $21.5 Million	-521,200 Reduced 53.44%	454,100 $19.3 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $2.69 Million - $3.06 Million	69,800 Added 7.71%	975,300 $42.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $3.98 Million - $4.83 Million	-115,500 Reduced 11.31%	905,500 $39.9 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $3.24 Million - $3.46 Million	-98,300 Reduced 8.78%	1,021,000 $37 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $24.3 Million - $28.2 Million	760,700 Added 212.13%	1,119,300 $39.7 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $2.85 Million - $3.02 Million	-85,700 Reduced 19.29%	358,600 $13 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $13.8 Million - $15.2 Million	444,300	444,300 $15.9 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account